Rznomics (476830.KQ) stock: key figures, P/E, revenue and dividend
Health Care · South Korea
Rznomics financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | – | 7.92 bn KRW |
| Gross profit | – | 7.92 bn KRW |
| Operating income | -12.86 bn KRW | -14.60 bn KRW |
| EBIT | -14.21 bn KRW | -99.82 bn KRW |
| Net income | -18.85 bn KRW | -103.81 bn KRW |
| Diluted EPS – continuing operations | -685.16 KRW | -3,773.28 KRW |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Rznomics
Rznomics Inc. develops RNA based gene therapies for cancers and intractable diseases. Its development stage product candidates include RZ-001_immune therapy combination product, which is in Phase 1b/2a stage for treating Hepatocellular carcinoma; RZ-001 (GBM) that is in Phase 1/2a stage for Glioblastoma; RZ-003, which is in discovery stage for Alzheimer; RZ-004, a pre-clinical product for Retinitis Pigmentosa; and RZ-005, a discovery stage product to treat Rett Syndrome. Rznomics Inc. was incorporated in 2017 and is headquartered in Seongnam-si, South Korea.
More stocks
- Shanghai Rongtai Health Tech (603579.SS)
- Zhejiang Meishuo Electric Technology Co. Ltd. A (301295.SZ)
- Future Generation Global Ltd (FGG.AX)
- Polynovo Ltd (PNV.AX)
- SAMPYO Cement Co. Ltd (038500.KQ)
- Yingde Greatchem Chemicals Co. Ltd. A (300804.SZ)
- Shape Australia Corporation Ltd (SHA.AX)
- Hangzhou Dadi Haiyang Environmental Protection Co. Ltd. (301068.SZ)
- Zhejiang Jianye Chemical Co Ltd (603948.SS)
- Shenzhen Genvict Technologies Co Ltd (002869.SZ)
- Qualipoly Chemical Corp (4722.TW)
- Jiangsu Hengshang Energy Conservation Technology Co. Ltd. A (603137.SS)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.